<DOC>
	<DOCNO>NCT00210483</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety almotriptan malate ( AXERT® ) treat acute migraine headache adolescent . Amotriptan malate ( AXERT® ) approve use treatment acute migraine headache without aura adult . In study , adolescent give single dose study medication treat one migraine headache .</brief_summary>
	<brief_title>A Study 3 Dosage Strengths Almotriptan Malate ( AXERT® ) Treatment Acute Migraine Adolescents</brief_title>
	<detailed_description>Amotriptan malate ( AXERT® ) approve use treatment acute migraine headache without aura adult . Other study show almotriptan effective well tolerate adult . Migraines teenagers/adolescents similar migraine adult , except duration usually less adolescent ( last 1 24 hour adolescent ) . This study evaluate usefulness almotriptan malate ( AXERT® ) treat acute migraine headache adolescent . This randomized , double-blind , parallel-group , placebo-controlled study . During 30-day run-in period , patient treat migraine normally would . During time , frequency severity headache record . At second visit , patient randomize ( like toss coin ) treatment group receive one oral dose almotriptan malate ( AXERT® ) 6.25 , 12.5 , 25 milligram placebo . Approximately number patient assign four treatment group . Patients take one-time dose next migraine least moderate severity occurs . Patients record assessment diary 24 hour study drug give help determine drug 's effect headache pain intensity . Patients return third visit within 2 14 day take study medication . A physical examination , electrocardiogram ( painless test heart ) , laboratory test perform first third visit . The objective study determine effectiveness tolerability 3 dosage strength almotriptan malate ( AXERT® ) adolescent migraine headache . Almotriptan oral tablet , 6.25 , 12.5 , 25 milligram , placebo</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Almotriptan</mesh_term>
	<criteria>Diagnosis migraine without aura &gt; 1 year Average 1 6 moderate severe migraine per month 2 month enter study Untreated migraine last least 4 hour At least 24 hour migraine Able tell difference migraine type headache If female , use birth control Chronic tension cluster headache Prolonged aura Specific type migraine &gt; 6 nonmigraine headache per month High blood pressure age Medical history specific significant condition affect liver , kidney , heart body system Conditions might affect way body absorbs process drug Positive blood test Hepatitis B C Recent head neck injury Body weight outside give parameter Unable take sumatriptan Abusing drug alcohol Pregnant breastfeeding Use antimigraine medication might interfere study , antimigraine medication &lt; 2 week , lithium monoamine oxidase inhibitor past 2 week , investigational drug within 2 month Refuse abstain take medicine ergotamine drug like almotriptan within 48 hour 24 hour take study medication , drug contain opiate antivomiting medicine within 48 hour 2 hour take study medication Use simple pain medicine within 24 hour ( like aspirin )</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>pain</keyword>
	<keyword>Migraine</keyword>
	<keyword>aura</keyword>
	<keyword>headache</keyword>
</DOC>